138 related articles for article (PubMed ID: 21909981)
21. Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status.
Bouchalova P; Nenutil R; Muller P; Hrstka R; Appleyard MV; Murray K; Jordan LB; Purdie CA; Quinlan P; Thompson AM; Vojtesek B; Coates PJ
J Pathol; 2014 Jul; 233(3):238-46. PubMed ID: 24687952
[TBL] [Abstract][Full Text] [Related]
22. Simvastatin reduces plasma membrane caveolae and caveolin-1 in uterine leiomyomas.
Afrin S; El Sabeh M; Miyashita-Ishiwata M; Charewycz N; Singh B; Borahay MA
Life Sci; 2022 Sep; 304():120708. PubMed ID: 35705139
[TBL] [Abstract][Full Text] [Related]
23. Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer.
Godina C; Tryggvadottir H; Bosch A; Borgquist S; Belting M; Isaksson K; Jernström H
Breast Cancer Res Treat; 2023 Jun; 199(2):335-347. PubMed ID: 37017811
[TBL] [Abstract][Full Text] [Related]
24. Caveolin involvement and modulation in breast cancer.
Aoki MN; Amarante MK; Oda JM; Watanabe MA
Mini Rev Med Chem; 2011 Nov; 11(13):1143-52. PubMed ID: 22353223
[TBL] [Abstract][Full Text] [Related]
25. Caveolin-1-containing extracellular vesicles transport adhesion proteins and promote malignancy in breast cancer cell lines.
Campos A; Salomon C; Bustos R; Díaz J; Martínez S; Silva V; Reyes C; Díaz-Valdivia N; Varas-Godoy M; Lobos-González L; Quest AF
Nanomedicine (Lond); 2018 Oct; 13(20):2597-2609. PubMed ID: 30338706
[TBL] [Abstract][Full Text] [Related]
26. A disease-associated frameshift mutation in caveolin-1 disrupts caveolae formation and function through introduction of a de novo ER retention signal.
Copeland CA; Han B; Tiwari A; Austin ED; Loyd JE; West JD; Kenworthy AK
Mol Biol Cell; 2017 Nov; 28(22):3095-3111. PubMed ID: 28904206
[TBL] [Abstract][Full Text] [Related]
27. Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration.
Ravid D; Chuderland D; Landsman L; Lavie Y; Reich R; Liscovitch M
Exp Cell Res; 2008 Sep; 314(15):2762-73. PubMed ID: 18598695
[TBL] [Abstract][Full Text] [Related]
28. Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy.
Teng YH; Tan WJ; Thike AA; Cheok PY; Tse GM; Wong NS; Yip GW; Bay BH; Tan PH
Breast Cancer Res; 2011 Apr; 13(2):R35. PubMed ID: 21457545
[TBL] [Abstract][Full Text] [Related]
29. Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers.
Santarpia L; Qi Y; Stemke-Hale K; Wang B; Young EJ; Booser DJ; Holmes FA; O'Shaughnessy J; Hellerstedt B; Pippen J; Vidaurre T; Gomez H; Valero V; Hortobagyi GN; Symmans WF; Bottai G; Di Leo A; Gonzalez-Angulo AM; Pusztai L
Breast Cancer Res Treat; 2012 Jul; 134(1):333-43. PubMed ID: 22538770
[TBL] [Abstract][Full Text] [Related]
30. Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA.
Li X; Chen X; Wen L; Wang Y; Chen B; Xue Y; Guo L; Liao N
Thorac Cancer; 2020 Jul; 11(7):1861-1868. PubMed ID: 32412177
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women.
Maruyama N; Miyoshi Y; Taguchi T; Tamaki Y; Monden M; Noguchi S
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):408-14. PubMed ID: 17202311
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive BRCA1 and BRCA2 mutational profile in Lithuania.
Janavičius R; Rudaitis V; Mickys U; Elsakov P; Griškevičius L
Cancer Genet; 2014 May; 207(5):195-205. PubMed ID: 25066507
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA‑192 inhibits cell proliferation and induces apoptosis in human breast cancer by targeting caveolin 1.
Chen P; Feng Y; Zhang H; Shi X; Li B; Ju W; Yu X; Zhang N; Luo X
Oncol Rep; 2019 Nov; 42(5):1667-1676. PubMed ID: 31485620
[TBL] [Abstract][Full Text] [Related]
34. Differential impact of caveolae and caveolin-1 scaffolds on the membrane raft proteome.
Zheng YZ; Boscher C; Inder KL; Fairbank M; Loo D; Hill MM; Nabi IR; Foster LJ
Mol Cell Proteomics; 2011 Oct; 10(10):M110.007146. PubMed ID: 21753190
[TBL] [Abstract][Full Text] [Related]
35. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
36. Significant association of caveolin-1 (CAV1) genotypes with breast cancer in Taiwan.
Liu LC; Su CH; Wang HC; Tsai CW; Chang WS; Ho CY; Wu CI; Li FJ; Lin CH; Lane HY; Bau DT
Anticancer Res; 2011 Oct; 31(10):3511-5. PubMed ID: 21965771
[TBL] [Abstract][Full Text] [Related]
37. Epithelial growth factor-induced phosphorylation of caveolin 1 at tyrosine 14 stimulates caveolae formation in epithelial cells.
Orlichenko L; Huang B; Krueger E; McNiven MA
J Biol Chem; 2006 Feb; 281(8):4570-9. PubMed ID: 16332692
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of PIK3CA mutations and the SNP rs17849079 in Arab breast cancer patients.
Karakas B; Colak D; Kaya N; Ghebeh H; Al-Qasem A; Hendrayani F; Toulimat M; Al-Tweigeri T; Park BH; Aboussekhra A
Cancer Biol Ther; 2013 Oct; 14(10):888-96. PubMed ID: 23982433
[TBL] [Abstract][Full Text] [Related]
39. BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays.
Bane AL; Beck JC; Bleiweiss I; Buys SS; Catalano E; Daly MB; Giles G; Godwin AK; Hibshoosh H; Hopper JL; John EM; Layfield L; Longacre T; Miron A; Senie R; Southey MC; West DW; Whittemore AS; Wu H; Andrulis IL; O'Malley FP
Am J Surg Pathol; 2007 Jan; 31(1):121-8. PubMed ID: 17197928
[TBL] [Abstract][Full Text] [Related]
40. Mutational profile of the CAV-1 gene in breast cancer cases in the ethnic Kashmiri population.
Syeed N; Husain SA; Abdullah S; Sameer AS; Chowdri NA; Nanda MS; Siddiqi MA
Asian Pac J Cancer Prev; 2010; 11(4):1099-105. PubMed ID: 21133631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
